Global Assets Advisory’s AbbVie ABBV Stock Holding History

Global Assets Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Buy	7,499 +325	+5%	+$69.9K	0.41%	62
2026 Q1	$1.56M	Buy	7,174 +90	+1%	+$20K	0.45%	49
2025 Q4	$1.62M	Buy	7,084 +215	+3%	+$49K	0.46%	50
2025 Q3	$1.59M	Buy	6,869 +612	+10%	+$125K	0.47%	52
2025 Q2	$1.19M	Sell	6,257 -5,275	-46%	-$980K	0.46%	55
2025 Q1	$2.16M	Buy	11,532 +6,969	+153%	+$1.35M	0.41%	56
2024 Q4	$819K	Sell	4,563 -496	-10%	-$91.2K	0.45%	56
2024 Q3	$996K	Buy	+5,059	New	+$944K	0.55%	49
2024 Q2	–	Sell	-4,832	Closed	-$873K	–	65
2024 Q1	$873K	Buy	+4,832	New	+$833K	0.53%	45
2023 Q4	–	Sell	-6,498	Closed	-$969K	–	56
2023 Q3	$969K	Sell	6,498 -2,215	-25%	-$325K	0.85%	32
2023 Q2	$1.18M	Buy	8,713 +2,214	+34%	+$325K	1.08%	27
2023 Q1	$1.04M	Buy	6,499 +1,248	+24%	+$191K	1.06%	25
2022 Q4	$849K	Sell	5,251 -400	-7%	-$61.3K	0.89%	29
2022 Q3	$827K	Buy	5,651 +1,546	+38%	+$222K	0.84%	29
2022 Q2	$629K	Buy	+4,105	New	+$627K	1.36%	17

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Global Assets Advisory's ABBV Position: Q2 2026 in Review

Global Assets Advisory increased its AbbVie (ABBV) stake by 4.5% in Q2 2026, buying an estimated $69.9K and bringing the position to 7,499 shares worth $1.88M. The position accounts for 0.41% of the portfolio, ranked #62.

Global Assets Advisory first reported a position in ABBV in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.16M in Q1 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Global Assets Advisory held 7,499 shares of AbbVie worth $1.88M as of Q2 2026.
Global Assets Advisory bought 325 AbbVie shares in Q2 2026, an estimated $69.9K.
AbbVie made up 0.41% of Global Assets Advisory's portfolio in Q2 2026, its #62 holding.
Global Assets Advisory first reported a position in AbbVie in Q2 2022 and has held it in 15 quarters since.
Global Assets Advisory's AbbVie position peaked at $2.16M in Q1 2025.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.